The biotechnology company, ImmuVen, uses a unique technology to discover and develop biotherapeutics that can treat a range of diseases including infectious diseases, cancer, and autoimmune disorders. Their platform enables the rapid selection and optimization of soluble TCR receptors, which are crucial for the development of effective biotherapeutics. ImmuVen is dedicated to improving patient outcomes and addressing unmet medical needs through the development of innovative drugs.